vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and HEALTHSTREAM INC (HSTM). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($138.3M vs $79.7M, roughly 1.7× HEALTHSTREAM INC). On growth, HEALTHSTREAM INC posted the faster year-over-year revenue change (7.4% vs 2.8%). HEALTHSTREAM INC produced more free cash flow last quarter ($13.0M vs $5.1M). Over the past eight quarters, HEALTHSTREAM INC's revenue compounded faster (4.7% CAGR vs 2.9%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.

CLB vs HSTM — Head-to-Head

Bigger by revenue
CLB
CLB
1.7× larger
CLB
$138.3M
$79.7M
HSTM
Growing faster (revenue YoY)
HSTM
HSTM
+4.6% gap
HSTM
7.4%
2.8%
CLB
More free cash flow
HSTM
HSTM
$7.8M more FCF
HSTM
$13.0M
$5.1M
CLB
Faster 2-yr revenue CAGR
HSTM
HSTM
Annualised
HSTM
4.7%
2.9%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
HSTM
HSTM
Revenue
$138.3M
$79.7M
Net Profit
$7.3M
Gross Margin
Operating Margin
11.5%
3.0%
Net Margin
5.3%
Revenue YoY
2.8%
7.4%
Net Profit YoY
1.2%
EPS (diluted)
$0.16
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
HSTM
HSTM
Q1 26
$138.3M
Q4 25
$138.3M
$79.7M
Q3 25
$134.5M
$76.5M
Q2 25
$130.2M
$74.4M
Q1 25
$123.6M
$73.5M
Q4 24
$129.2M
$74.2M
Q3 24
$134.4M
$73.1M
Q2 24
$130.6M
$71.6M
Net Profit
CLB
CLB
HSTM
HSTM
Q1 26
$7.3M
Q4 25
$4.9M
Q3 25
$14.2M
$6.1M
Q2 25
$10.6M
$5.4M
Q1 25
$-154.0K
$4.3M
Q4 24
$7.4M
Q3 24
$11.7M
$5.7M
Q2 24
$9.0M
$4.2M
Gross Margin
CLB
CLB
HSTM
HSTM
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
HSTM
HSTM
Q1 26
11.5%
Q4 25
11.5%
3.0%
Q3 25
15.6%
9.9%
Q2 25
11.7%
7.9%
Q1 25
3.6%
6.0%
Q4 24
11.0%
6.3%
Q3 24
14.7%
8.9%
Q2 24
12.3%
6.2%
Net Margin
CLB
CLB
HSTM
HSTM
Q1 26
5.3%
Q4 25
3.6%
Q3 25
10.6%
8.0%
Q2 25
8.2%
7.2%
Q1 25
-0.1%
5.9%
Q4 24
5.7%
Q3 24
8.7%
7.8%
Q2 24
6.9%
5.8%
EPS (diluted)
CLB
CLB
HSTM
HSTM
Q1 26
$0.16
Q4 25
$0.11
$0.09
Q3 25
$0.30
$0.20
Q2 25
$0.22
$0.18
Q1 25
$0.00
$0.14
Q4 24
$0.15
$0.16
Q3 24
$0.25
$0.19
Q2 24
$0.19
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
HSTM
HSTM
Cash + ST InvestmentsLiquidity on hand
$22.8M
$36.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$279.8M
$354.0M
Total Assets
$597.0M
$520.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
HSTM
HSTM
Q1 26
$22.8M
Q4 25
$22.7M
$36.2M
Q3 25
$25.6M
$53.5M
Q2 25
$31.2M
$52.1M
Q1 25
$22.1M
$77.3M
Q4 24
$19.2M
$59.5M
Q3 24
$21.5M
$57.5M
Q2 24
$17.7M
$46.1M
Total Debt
CLB
CLB
HSTM
HSTM
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
HSTM
HSTM
Q1 26
$279.8M
Q4 25
$266.0M
$354.0M
Q3 25
$271.3M
$349.2M
Q2 25
$261.3M
$350.6M
Q1 25
$253.4M
$362.8M
Q4 24
$246.6M
$359.4M
Q3 24
$250.7M
$355.5M
Q2 24
$240.3M
$349.2M
Total Assets
CLB
CLB
HSTM
HSTM
Q1 26
$597.0M
Q4 25
$584.0M
$520.4M
Q3 25
$591.4M
$499.9M
Q2 25
$602.1M
$500.1M
Q1 25
$591.5M
$524.0M
Q4 24
$585.1M
$510.8M
Q3 24
$600.5M
$502.8M
Q2 24
$597.8M
$499.6M
Debt / Equity
CLB
CLB
HSTM
HSTM
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
HSTM
HSTM
Operating Cash FlowLast quarter
$37.2M
$13.2M
Free Cash FlowOCF − Capex
$5.1M
$13.0M
FCF MarginFCF / Revenue
3.7%
16.3%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
5.12×
TTM Free Cash FlowTrailing 4 quarters
$27.1M
$59.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
HSTM
HSTM
Q1 26
$37.2M
Q4 25
$7.9M
$13.2M
Q3 25
$8.5M
$18.0M
Q2 25
$13.9M
$5.0M
Q1 25
$6.7M
$27.1M
Q4 24
$20.6M
$11.2M
Q3 24
$13.1M
$19.1M
Q2 24
$17.1M
$6.5M
Free Cash Flow
CLB
CLB
HSTM
HSTM
Q1 26
$5.1M
Q4 25
$5.0M
$13.0M
Q3 25
$6.5M
$17.9M
Q2 25
$10.4M
$2.7M
Q1 25
$3.9M
$26.0M
Q4 24
$17.4M
$11.0M
Q3 24
$10.4M
$18.8M
Q2 24
$14.3M
$6.3M
FCF Margin
CLB
CLB
HSTM
HSTM
Q1 26
3.7%
Q4 25
3.6%
16.3%
Q3 25
4.8%
23.4%
Q2 25
8.0%
3.6%
Q1 25
3.1%
35.4%
Q4 24
13.4%
14.8%
Q3 24
7.7%
25.8%
Q2 24
10.9%
8.8%
Capex Intensity
CLB
CLB
HSTM
HSTM
Q1 26
Q4 25
2.1%
0.3%
Q3 25
1.5%
0.1%
Q2 25
2.7%
3.1%
Q1 25
2.3%
1.4%
Q4 24
2.5%
0.3%
Q3 24
2.0%
0.4%
Q2 24
2.2%
0.2%
Cash Conversion
CLB
CLB
HSTM
HSTM
Q1 26
5.12×
Q4 25
1.61×
Q3 25
0.60×
2.96×
Q2 25
1.31×
0.93×
Q1 25
6.25×
Q4 24
2.78×
Q3 24
1.12×
3.34×
Q2 24
1.90×
1.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

HSTM
HSTM

Subscription Services$77.0M97%
Professional Services$2.7M3%

Related Comparisons